Quick Answer
Edwards Lifesciences Corp reported Total Assets of $13.70 billion for fiscal year 2025.
Edwards Lifesciences Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $13.70B | +4.9% |
| 2024 | $13.06B | +39.4% |
| 2023 | $9.36B | +12.9% |
| 2022 | $8.29B | -2.5% |
| 2021 | $8.50B | +17.5% |
| 2020 | $7.24B | +11.5% |
| 2019 | $6.49B | +21.9% |
| 2018 | $5.32B | -6.0% |
| 2017 | $5.67B | +25.6% |
| 2016 | $4.51B | +11.2% |
| 2015 | $4.06B | +15.1% |
| 2014 | $3.52B | +30.0% |
| 2013 | $2.71B | +22.0% |
| 2012 | $2.22B | +12.2% |
| 2011 | $1.98B | +12.1% |
| 2010 | $1.77B | +9.4% |
| 2009 | $1.62B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.27B | +2.3% | -1.6% |
| June 30, 2025 | $13.49B | +33.6% | +3.6% |
| March 31, 2025 | $13.02B | +33.7% | -0.3% |
| December 31, 2024 | $13.06B | +39.4% | +0.6% |
| September 30, 2024 | $12.97B | +38.4% | +28.4% |
| June 30, 2024 | $10.10B | +12.2% | +3.7% |
| March 31, 2024 | $9.74B | +12.5% | +4.0% |
| December 31, 2023 | $9.36B | +12.9% | -0.1% |
- Edwards Lifesciences Corp showed an increase of +4.9% in Total Assets compared to the prior fiscal year.
- Over the 2009–2025 period, Edwards Lifesciences Corp’s total assets has grown by 747.9% (from $1.62 billion to $13.70 billion).
- The most recent figure is from Edwards Lifesciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: